Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-Week results

Robert L. Murphy*, Ian Sanne, Pedro Cahn, Praphan Phanuphak, Lisa Percival, Thomas Kelleher, Michael Giordano

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

169 Scopus citations

Fingerprint

Dive into the research topics of 'Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-Week results'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science